Patents by Inventor Abbas Samadi

Abbas Samadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8598339
    Abstract: The present invention features novel withanolides, as well as analogs and salts thereof, for use in the treatment of proliferative disease, cardiovascular disease, neurodegenerative disease and inflammatory disease.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: December 3, 2013
    Assignee: University of Kansas
    Inventors: Barbara N. Timmermann, Jeffrey Aube, Huaping Zhang, Rao Gollapudi, Mark S. Cohen, Abbas Samadi, Hashim Fakhsuddin-Motiwala
  • Publication number: 20120196815
    Abstract: The present invention features novel withanolides, as well as analogs and salts thereof, for use in the treatment of proliferative disease, cardiovascular disease, neurodegenerative disease and inflammatory disease.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 2, 2012
    Applicant: Kansas University Center for Technology Commercialization
    Inventors: Barbara N. Timmermann, Jeffrey Aube, Huaping Zhang, Rao Gollapudi, Mark S. Cohen, Abbas Samadi, Hashim Fakhruddin-Motiwala
  • Publication number: 20060280812
    Abstract: Compositions and methods for treatment of individuals diagnosed with a dystrophin deficiency are disclosed. In particular, inhibitors of NF?B activation, such as pyrrolidine dithiocarbamate (PDTC), have been shown to prevent and reverse muscle damage in animals lacking dystrophin. Such compositions and methods are useful in the treatment of individuals with muscular dystrophy.
    Type: Application
    Filed: May 24, 2006
    Publication date: December 14, 2006
    Inventors: C. Carlson, Abbas Samadi